{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:59:41Z","timestamp":1791644381103,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejogrb.2021.10.006","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T17:32:48Z","timestamp":1633627968000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Implementing placental-growth-factor (PLGF) measurements in suspected pre-eclampsia----Challenges in clinical practice"],"prefix":"10.1016","volume":"266","author":[{"given":"Maria","family":"Wojcik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris","family":"Karouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucheta","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6218-1781","authenticated-orcid":false,"given":"Habiba","family":"Kapaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.006_b0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1471-0528.2004.00071.x","article-title":"Is pre-eclampsia more than one disease?","volume":"111","author":"Vatten","year":"2004","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.ejogrb.2021.10.006_b0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1471-0528.1999.tb08396.x","article-title":"Evaluation of a definition of pre-eclampsia","volume":"106","author":"North","year":"1999","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.006_b0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2021.10.006_b0020","doi-asserted-by":"crossref","unstructured":"Macdonald-Wallis C, Lawlor DA, Heron J, Fraser A, Nelson SM, Tilling K. Relationships of risk factors for pre-eclampsia with patterns of occurrence of isolated gestational proteinuria during normal term pregnancy. PLoS One 2011;6. https:\/\/doi.org\/10.1371\/journal.pone.0022115.","DOI":"10.1371\/journal.pone.0022115"},{"issue":"16","key":"10.1016\/j.ejogrb.2021.10.006_b0025","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.2016.18315","article-title":"Preeclampsia Screening","volume":"317","author":"Henderson","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.10.006_b0030","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/01.HYP.30.6.1531","article-title":"Diagnosing gestational hypertension and preeclampsia with the 24-hour mean of blood pressure","volume":"30","author":"Hermida","year":"1997","journal-title":"Hypertension"},{"issue":"jul09 1","key":"10.1016\/j.ejogrb.2021.10.006_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4342","article-title":"Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: Systematic review and meta-analysis","volume":"345","author":"Morris","year":"2012","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ejogrb.2021.10.006_b0040","first-page":"1390","article-title":"Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis. BJOG An Int","volume":"126","author":"Duhig","year":"2019","journal-title":"J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.10.006_b0045","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/HYPERTENSIONAHA.117.09499","article-title":"Estimating the Cost of Preeclampsia in the Healthcare System","volume":"70","author":"Fox","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2021.10.006_b0050","article-title":"Diagnosis and management of preeclampsia","volume":"70","author":"Wagner","year":"2004","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.006_b0055","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized Interventional Study on Prediction of Preeclampsia\/Eclampsia in Women with Suspected Preeclampsia: INSPIRE","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.006_b0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejogrb.2021.10.006_b0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating Angiogenic Factors and the Risk of Preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2021.10.006_b0070","unstructured":"National Institute for Health and Care Excellence. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1\/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor\/BRAHMS PlGF plus Kryptor PE ratio). Https:\/\/WwwNiceOrgUk\/Guidance\/Dg23\/Chapter\/1-Recommendations 2016. https:\/\/www.nice.org.uk\/guidance\/dg23 (accessed July 2, 2021)."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.10.006_b0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of Preeclampsia-Related Adverse Outcomes with the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)\/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.006_b0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)\/PlGF (Placental Growth Factor) Ratio in Asian Women with Suspected Preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.10.006_b0085","first-page":"95","article-title":"Evaluation of sFlt-1\/PlGF ratio for predicting and improving clinical management of pre-eclampsia: Experience in a specialized perinatal care center. Ann","volume":"38","author":"Caillon","year":"2018","journal-title":"Lab Med"},{"key":"10.1016\/j.ejogrb.2021.10.006_b0090","unstructured":"National Institute for Health and Care Excellence. Review of DG23: PLGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt1\/PLGF ratio, DELFIA Xpress PLGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor\/BRAHMS PLGF plus Kryptor PE ratio). Cent Heal Technol Eval 2016. https:\/\/www.nice.org.uk\/guidance\/dg23\/evidence\/review-decision-february-2020-pdf-8830114525 (accessed June 15, 2021)."},{"key":"10.1016\/j.ejogrb.2021.10.006_b0095","unstructured":"National Health Service England, National Health Service Improvement. Innovation and Technology Payment - Technical Notes 2020. https:\/\/www.england.nhs.uk\/aac\/wp-content\/uploads\/sites\/50\/2020\/12\/PAR0091-itp-technical-guidance-20-20-v8.pdf (accessed July 21, 2021)."},{"key":"10.1016\/j.ejogrb.2021.10.006_b0100","unstructured":"Sucheta Jindal. PlGF ratio in the management of suspected Pre-eclampsia 2020."},{"key":"10.1016\/j.ejogrb.2021.10.006_b0105","unstructured":"National Institute for Health and Care Excellence Clinical Knowledge Summaries. Hypertension in Pregnancy 2020. https:\/\/cks.nice.org.uk\/topics\/hypertension-in-pregnancy\/ (accessed July 21, 2021)."},{"issue":"3","key":"10.1016\/j.ejogrb.2021.10.006_b0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: Implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.10.006_b0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (Soluble fms-Like Tyrosine Kinase-1\/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women with Clinical Diagnosis of Preeclampsia","volume":"76","author":"Lea\u00f1os-Miranda","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2021.10.006_b0120","unstructured":"National Institute for Health and Care Excellence. Resource Impact Template: PIGF-based testing to help diagnose suspected pre-eclampsia 2016. https:\/\/www.nice.org.uk\/guidance\/dg23\/resources (accessed July 21, 2021)."},{"issue":"11","key":"10.1016\/j.ejogrb.2021.10.006_b0125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1440-1681.1995.tb01937.x","article-title":"THE PHYSIOLOGY OF PRE-ECLAMPSIA","volume":"22","author":"Brown","year":"1995","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.10.006_b0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.siny.2017.11.004","article-title":"Screening for fetal growth restriction and placental insufficiency","volume":"23","author":"Audette","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2021.10.006_b0135","unstructured":"National Health Service. MedTech Funding Mandate policy 2021\/22 2021. https:\/\/www.england.nhs.uk\/aac\/wp-content\/uploads\/sites\/50\/2021\/01\/mtfm-policy-guidance-jan-2021.pdf (accessed July 21, 2021)."},{"issue":"03","key":"10.1016\/j.ejogrb.2021.10.006_b0140","doi-asserted-by":"crossref","DOI":"10.1055\/s-0035-1548683","article-title":"PreOS (Preeclampsia Open Study), a Multicenter, Prospective, Non-Interventional Study Evaluating the Influence of the sFlt-1\/PlGF Ratio on Physician Decision-Making in Pregnant Women with Suspicion of Preeclampsia","volume":"75","author":"Stepan","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.10.006_b0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/uog.15997","article-title":"sFlt-1\/PlGF ratio test for pre-eclampsia: an economic assessment for the UK","volume":"48","author":"Vatish","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ejogrb.2021.10.006_b0150","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1055\/s-0040-1713916","article-title":"Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis","volume":"42","author":"S\u00e1","year":"2020","journal-title":"Rev Bras Ginecol e Obstet"},{"issue":"10","key":"10.1016\/j.ejogrb.2021.10.006_b0155","doi-asserted-by":"crossref","first-page":"e0164276","DOI":"10.1371\/journal.pone.0164276","article-title":"Placental growth factor (PLGF) in women with suspected pre-eclampsia prior to 35 weeks\u2019 gestation: A budget impact analysis","volume":"11","author":"Duckworth","year":"2016","journal-title":"PLoS ONE"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:55:32Z","timestamp":1759557332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521004954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":31,"alternative-id":["S0301211521004954"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.10.006","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing placental-growth-factor (PLGF) measurements in suspected pre-eclampsia----Challenges in clinical practice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}